QUEENS, NY - 
(NewMediaWire) - July 3, 2024 - House of Strains, a new cannabis dispensary, opened its doors on June 1st, 2024, in North Flushing, Queens. As the first minority-owned CAURD Licensee in the area, House of Strains has chosen Alleaves' advanced Point of Sale (POS) software to power its operations, ensuring compliance and efficiency.
Founded by Jason Winn and Bryan Muczynski, House of Strains is dedicated to transforming cannabis culture with a commitment to community engagement and excellence. The dispensary aims to provide a sophisticated and inclusive environment for its customers.
Alleaves' comprehensive POS system, Alleaves SELL, provides House of Strains with a robust platform that includes secure access levels, cash management tracking, and location-based KPIs, which help drive accountability and growth in sales operations. With real-time state traceability reporting, integrated payment solutions, powerful data analytics, and dedicated customer support, Alleaves SELL ensures that cannabis retail operations are secure, efficient, and compliant.
Alleaves owns BioTrack, the official New York State Cannabis Traceability System. This seamless integration ensures that dispensaries using Alleaves’ software can automatically sync with the state’s tracking requirements, enhancing compliance and operational efficiency for cannabis businesses in New York.
John Magna, CEO of Beast Coast Group dba House of Strains, commented on their choice of Alleaves: “When shopping for POS systems, I wanted reliable technology, ease of operation, great customer service, and a comprehensive program to cover all my needs without integrating multiple systems. Alleaves provided all of this and more. Their support during our OCM inspection was exceptional, and their system's features have proven invaluable in our operations.”
About BioTrack Alleaves:
BioTrack Alleaves is a leading provider of technology, analytics, and payment solutions for the cannabis industry. The company's comprehensive platform offers robust compliance management, detailed inventory tracking, and an easy-to-use point-of-sale system. BioTrack Alleaves’ solutions are designed to meet the unique needs of the cannabis industry, ensuring regulatory compliance and operational efficiency. With a presence in 38 states and 13 countries, BioTrack Alleaves is trusted by businesses and governments worldwide to manage and monitor cannabis operations. For more information, visit Alleaves’ website at www.alleaves.com.
Cautionary Statements Regarding Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of applicable laws. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions or variations of these words. Forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond the control of BioTrack, are not guarantees of future results, and are subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements, and caution must be exercised in relying on forward-looking statements. Factors that could cause actual results to differ include, but are not limited to, those risks and uncertainties associated with: the impact of the COVID-19 pandemic on BioTrack's business, operations, strategy, and goals; BioTrack's ability to execute on its strategy; the timing of the introduction of new product offerings; and other risks and uncertainties affecting BioTrack and its operations. Forward-looking statements contained in this announcement are made as of the date hereof, and BioTrack undertakes no duty to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable law.
Alleaves Media Contact:
Emily Vetter
1.800.797.4711
